Yuanjin Zhang | Medicine | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Yuanjin Zhang | Medicine | Best Researcher Award

Peking University Third Hospital | China

Dr. Yuanjin Zhang is a distinguished neurologist and chief physician at Peking University Third Hospital, recognized for her pioneering work in neurotherapeutics, neurodegeneration, and digital medicine. Educated and trained at Peking University Health Science Center, she combines strong clinical expertise with innovative research in amyotrophic lateral sclerosis, neuropathic pain, and AI-driven healthcare technologies. Her professional journey bridges academic medicine and industry, where she has led numerous multi-center clinical and translational projects focused on diabetic neuropathy, stroke, and cognitive disorders. Dr. Zhang’s research interests encompass neurological and vascular sciences, digital biomarkers, mHealth platforms, and precision neurorehabilitation. She possesses advanced skills in clinical data analytics, bioinformatics, AI algorithm development, and translational neurotechnology, supported by extensive NIH and NSFC-funded collaborations. Her contributions to journals such as BMC Neurology, Scientific Reports, and JMIR MHealth UHealth highlight her global impact on digital neurotherapeutics. As a reviewer for leading journals and an active member of national neurology and neuroscience societies, she promotes interdisciplinary collaboration across China’s medical and research communities. Honored for her leadership and scientific innovation, Dr. Zhang continues to shape the future of neurology through AI-enabled clinical care and patient-centered neurotechnology, embodying excellence in research, mentorship, and translational impact.

Profile: ORCID

Featured Publications

Hanna Küpper | Neuroscience | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Hanna Küpper | Neuroscience | Best Researcher Award

University hospital in Tübingen | Germany

Dr. Hanna Küpper is a dedicated neuropaediatrician and specialist registrar at the University Hospital Tübingen, where she focuses on advancing the understanding and diagnosis of paediatric neuromuscular diseases. She completed her medical degree at the University of Freiburg, complemented by international academic experiences at the Université Paris-Sud and St. Thomas Hospital London, followed by specialized medical training in Bonn, Tübingen, and Vogtareuth. Her research centers on high-resolution ultrasound imaging of peripheral nerves, skeletal, and respiratory muscles in children affected by hereditary and inflammatory neuropathies, myopathies, and spinal muscular atrophy. With ongoing collaborations with institutions such as RadboudUMC Nijmegen, Smartcare, and the FAIR-DMD registry, Dr. Küpper contributes to the development of standardized imaging protocols that link clinical and neurophysiological findings. Her scientific expertise extends to consulting for pharmaceutical projects with Roche in areas like spinal muscular atrophy and Duchenne muscular dystrophy. She has authored multiple peer-reviewed publications and is an active member of several professional organizations, including DGKJ, GNP, EPNS, DGKN, DGfE, and DEGUM. Recognized for her commitment to translational research and clinical excellence, Dr. Küpper’s work bridges advanced imaging techniques with patient-centered care, reinforcing her position as a leading figure in paediatric neuroimaging and neuromuscular research.

Profile: ORCID

Featured Publications

Alina Diana Zamfir | Brain Science | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof. Dr. Alina Diana Zamfir | Brain Science | Best Researcher Award

National Institute for R&D in Electrochemistry and Condensed Matter | Romania

Dr. Alina Diana Zamfir is a distinguished Romanian physicist and professor known for her pioneering research in biophysics, mass spectrometry, and biomolecular analysis. She earned her academic degrees in physics from leading Romanian universities, including a Ph.D. in Physics and two habilitations in Biophysics and Physics from prestigious institutions in Romania and Germany. Currently serving as a Senior Scientific Researcher at the National Institute for Research and Development in Electrochemistry and Condensed Matter and as a Professor at Aurel Vlaicu University of Arad, she also mentors doctoral candidates at the West University of Timisoara. Her professional journey includes research and teaching appointments in Germany and collaborations with international universities and corporations. Dr. Zamfir’s research interests focus on mass spectrometry-based proteomics, glycomics, and microfluidics for the analysis of complex biological systems. She is highly skilled in advanced spectrometric analysis, microfluidic platform development, and molecular characterization of biomolecules. A recipient of numerous awards, including the Romanian Academy Prize, the Elsevier Top Cited Article Award, and the Wiley Award, she is also President of the Romanian Society for Mass Spectrometry. Her extensive contributions to molecular biophysics and analytical chemistry continue to advance biomedical innovation and interdisciplinary scientific excellence worldwide.

Profile: Google scholar

Featured Publications

Natalia N. Kudryavtseva | Neurobiology | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof. Dr. Natalia N. Kudryavtseva | Neurobiology | Best Researcher Award

Institute of Cytology and Genetics of SB RAS | Russia

Professor Natalia N. Kudryavtseva is a highly distinguished neuroscientist and leading researcher at the I.P. Pavlov Institute of Physiology RAS in Saint Petersburg and the Institute of Cytology and Genetics SB RAS in Novosibirsk, with extensive academic and research contributions in behavioral pharmacology, neurogenetics, and biological psychiatry. She completed her education at Novosibirsk State University in physiology and advanced to hold key positions as junior, senior, and leading researcher, later becoming head of the Neurogenetics of Social Behaviour Sector and the Neuropathology Modelling Laboratory. Her professional journey includes visiting research at Cold Spring Harbor Laboratory in the United States, along with teaching as professor of physiology at Novosibirsk State University. Her research interests span behavioral genetics, social biology, psychopharmacology, transcriptomic analysis, and modelling of psychoemotional disorders, particularly through the sensory contact model she developed, widely applied in the study of chronic social conflict and neuropsychiatric mechanisms. She is skilled in neurogenomics, experimental neurobiology, and psychopharmacological correction, with more than one hundred eighty publications and several books. She is an active member of international research societies and has collaborated with institutions across Europe and the USA. Recognized for her pioneering contributions, with a citation index exceeding four thousand and an h-index of thirty-seven, she has received numerous honors for advancing knowledge on the neurobiology of aggression and psychoemotional disorders, making her a truly deserving candidate for international recognition.

Profile: ORCID

Featured Publications

Sarah Leibowitz | Behavioral Neurobiology | Most Cited Article Award

Published on by Cognitive Scientist Awards

Dr. Sarah Leibowitz | Behavioral Neurobiology | Most Cited Article Award

The Rockefeller University | United States

Dr. Sarah F. Leibowitz is a Research Associate Professor at The Rockefeller University in the Laboratory of Behavioral Neurobiology. With a career dedicated to uncovering the neural basis of addiction, she focuses on how the brain regulates consumption of substances like alcohol and nicotine, as well as high-fat and high-sugar foods. Her pioneering work explores the transition from casual intake to substance dependence, linking specific brain mechanisms to addictive behaviors. Dr. Leibowitz’s research also highlights how emotional traits—such as impulsivity and anxiety—influence substance use. In recent years, she has expanded her work to investigate how maternal diet and drug exposure during pregnancy affect the brain development and behavior of offspring. Her studies reveal persistent neural and behavioral changes that may increase vulnerability to addiction later in life. Through her research, she aims to identify early indicators of addiction risk and explore preventive strategies for substance abuse disorders.

Profile

ORCID

Education

Dr. Sarah F. Leibowitz earned her Ph.D. in behavioral neurobiology, establishing her foundation in neuroscience and psychobiology. Although specific details of her academic institutions are not publicly disclosed, her academic trajectory clearly reflects rigorous training in neurobiology, endocrinology, and developmental neuroscience. Her education emphasized the interplay between brain structure, behavior, and environmental stimuli—especially as related to addiction and nutrition. Over the course of her doctoral and postdoctoral work, she developed specialized expertise in rodent models, neurochemical techniques, and behavioral neuroscience. Her educational background has equipped her to contribute significantly to the understanding of the neural mechanisms underlying addiction, impulsivity, and maternal influences on brain development. Dr. Leibowitz’s academic formation has not only shaped her robust research career but also positioned her as a mentor and thought leader in the intersection of behavioral neuroscience, addiction research, and developmental psychobiology.

 Experience

Dr. Sarah Leibowitz brings decades of experience in behavioral neuroscience, serving as a Research Associate Professor at The Rockefeller University. In this role, she leads research exploring how neurochemical circuits in the brain influence the consumption of addictive substances and palatable foods. Her experience spans experimental neurobiology, developmental studies, and translational addiction research, using advanced rodent models to simulate human behavioral patterns. She has worked extensively on characterizing the neural pathways that control emotional traits such as impulsivity and anxiety, which predispose individuals to addiction. In addition, Dr. Leibowitz has pioneered investigations into prenatal programming—studying how maternal substance use affects offspring neurodevelopment and behavior. Her career has been marked by interdisciplinary collaborations, significant grant support, and mentoring emerging scientists. Dr. Leibowitz’s extensive lab-based research experience has positioned her at the forefront of studies on addiction vulnerability, making meaningful contributions to both basic neuroscience and potential clinical applications.

Awards and Honors

While specific awards and honors for Dr. Sarah F. Leibowitz are not publicly detailed, her long-standing appointment at The Rockefeller University—a prestigious research institution—attests to her outstanding contributions in behavioral neurobiology. Recognition in the scientific community is reflected through her published research, influential collaborations, and leadership in addiction-related neuroscience. She is frequently cited in peer-reviewed journals, indicating strong academic impact and recognition from fellow researchers. Her studies addressing prenatal influences on addiction vulnerability have garnered widespread attention in developmental neuroscience and public health sectors. In addition to academic merit, Dr. Leibowitz’s role as a mentor and educator suggests acknowledgment of her commitment to training the next generation of scientists. The significance and longevity of her research position imply that she has received competitive research funding and peer-reviewed grants, further recognizing the value of her work in advancing understanding of substance use disorders.

Research Focus

Dr. Leibowitz’s research focuses on the neurobiological mechanisms underlying addiction, particularly the transition from use to dependence on substances like alcohol, nicotine, and palatable foods. Her laboratory investigates how neurochemical pathways in various brain regions drive compulsive consumption and are influenced by traits such as novelty seeking, impulsivity, and anxiety. A major area of her research explores the developmental origins of addiction: how maternal consumption of drugs or high-fat/high-sugar diets during pregnancy alters brain development and long-term behavior in offspring. These studies reveal that such prenatal exposures can “reprogram” the brain, increasing susceptibility to substance use disorders in adolescence and adulthood. Through rodent models, Dr. Leibowitz aims to identify biomarkers and early-life predictors of addiction risk, as well as investigate potential interventions for prevention. Her multidisciplinary approach integrates behavioral neuroscience, endocrinology, and developmental biology, contributing valuable insights into addiction’s origins, progression, and possible prevention strategies.

Publications

Title: Neurological Disorders Induced by Drug Use: Effects of Adolescent and Embryonic Drug Exposure on Behavioral Neurodevelopment
Year: 2024
Citations: 2

Title: Utility of the Zebrafish Model for Studying Neuronal and Behavioral Disturbances Induced by Embryonic Exposure to Alcohol, Nicotine, and Cannabis
Year: 2023
Citations: 8

Title: Role of Chemokine Cxcl12a in Mediating the Stimulatory Effects of Ethanol on Embryonic Development of Subpopulations of Hypocretin/Orexin Neurons and Their Projections
Year: 2023
Citations: 10

Title: Embryonic ethanol exposure induces ectopic Hcrt and MCH neurons outside hypothalamus in rats and zebrafish: Role in ethanol‐induced behavioural disturbances
Year: 2022
Citations: 18

Conclusion

Dr. Sarah F. Leibowitz’s work stands at the intersection of neuroscience, behavior, and developmental biology, providing groundbreaking insights into addiction, prenatal brain development, and preventive strategies for substance use disorders, making her a leading figure in behavioral neurobiology and addiction research.

 

Camille Blackman | Neurology and Gender-Affirming Care | Best Researcher Award

Published on by Cognitive Scientist Awards

Ms. Camille Blackman | Neurology and Gender-Affirming Care | Best Researcher Award

Camille Blackman is a dedicated medical student and multidisciplinary researcher with a passion for advancing gender-affirming healthcare and surgical education. Currently pursuing her MD at the University of Illinois College of Medicine, she brings a diverse background in anthropology, emergency medicine, and clinical research. Camille’s clinical experiences range from working as an EMT and physical therapist assistant to serving as a medical assistant in dermatology. Her current research at Johns Hopkins Center for Transgender and Gender Expansive Health centers on surgical outcomes, educational innovation, and health equity. She has published and presented nationally on topics like craniofacial surgery, sexual medicine, and transgender health. Outside of medicine, she is a nationally competitive runner and co-founder of Nameless Track Club. Camille also contributes to mentoring, leadership development, and medical education reform. Fluent in English and French, she exemplifies a well-rounded, compassionate, and forward-thinking physician in training.

Profile

🎓 Education

Camille Blackman’s academic journey reflects her interdisciplinary strength and commitment to health equity. She holds a Bachelor of Arts in Cultural Anthropology from Northwestern University (2012–2016), where she was also a Division 1 athlete. To transition into a medical career, she completed a post-baccalaureate pre-medical program at DePaul University (2016–2017). Camille is currently a Doctor of Medicine (MD) candidate at the University of Illinois College of Medicine, expected to graduate in 2026. Her medical education is enhanced by participation in the Surgical Exploration and Discovery (SEAD) program and leadership in multiple mentorship initiatives. Her academic excellence is evidenced by her involvement in high-impact research, her role as an M3 mentor, and her selection for honors like Academic All-Big Tens. Throughout her academic path, she has consistently demonstrated a commitment to inclusion, excellence in scholarship, and innovation in clinical care, especially for underserved populations such as the transgender and gender-diverse community.

🧪 Experience

Camille Blackman has built a robust portfolio of healthcare experience over nearly a decade. As a current research trainee at the Johns Hopkins Center for Transgender and Gender Expansive Health, she contributes to cutting-edge projects focused on surgical outcomes and health equity. Prior to that, she worked as a medical assistant at the Illinois Dermatology Institute (2020–2023), a physical therapist assistant at RUSH Rehabilitation (2018–2021), and an EMT at Medical Express Ambulance (2018–2020). Her roles have spanned both emergency and outpatient care, giving her a comprehensive clinical foundation. In addition to her hands-on experience, she’s actively involved in medical education as a mentor and peer leader at UICOM. Camille also volunteers in both clinical and community settings, including Face the Future Foundation and Ann & Robert H. Lurie Children’s Hospital. Her practical and research experience across diverse settings reinforces her trajectory as a future physician-leader in gender-affirming and reconstructive surgery.

🏅 Awards and Honors

Camille Blackman has been recognized for both academic and athletic excellence. She is a recipient of the prestigious Academic All-Big Ten award (2013–2016) and earned the John and Rita Canning and Dinn Brothers Student-Athlete Scholarships while at Northwestern University. In athletics, she is a Tracksmith-sponsored elite runner and has posted competitive times in major races, including a 2:48 marathon and top finishes in the Chicago 13.1 and Shamrock Shuffle. Her early accolades include the Western Massachusetts Athlete of the Year and the Tommy Cochary High School Mile Grant. As a medical student, she was selected for the Surgical Exploration and Discovery (SEAD) program and received a $25,000 pilot grant from the Hopkins Business of Health Initiative as a co-investigator for transgender health systems innovation. Her honors reflect a rare combination of scientific acumen, athletic discipline, and community impact, affirming her multifaceted contributions to medicine and public health.

🔬 Research Focus

Camille Blackman’s research centers on gender-affirming care, surgical education, and health disparities. At the Johns Hopkins Center for Transgender and Gender Expansive Health, she explores clinical outcomes related to chest masculinization and hormone therapy, and contributes to the development of transgender health infrastructure. She has authored and co-authored multiple peer-reviewed publications on subjects such as craniofacial surgery techniques, body mass index implications in gender-affirming surgeries, and innovative educational approaches like clay modeling in anatomy instruction. Camille’s forthcoming book chapters on vaginoplasty and transgender care centers further establish her as an emerging scholar in surgical education and gender health equity. She has presented her work at high-profile conferences, including the Plastic Surgery Research Council and the Sexual Medicine Society of North America. Through her research, Camille aims to enhance inclusivity, clinical outcomes, and the surgical learning experience, particularly in areas where historically marginalized populations have faced significant healthcare gaps.

✅ Conclusion

Camille Blackman is a future physician and trailblazer in gender-affirming healthcare whose interdisciplinary expertise, clinical compassion, and research innovation are advancing inclusive medicine, educational reform, and equity in surgical outcomes.

Publications

Forshing Lui | Neurology | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof. Forshing Lui | Neurology | Best Researcher Award

Dr. For-Shing Lui, a U.S. citizen and licensed neurologist in California, the UK, and Hong Kong, is an esteemed academic and clinician with over four decades of international experience in neurology and internal medicine, currently serving as Professor of Neurology at California Northstate University College of Medicine (CNUCOM), where he contributes significantly to medical education, curriculum development, and professional regulatory boards.

Profile

Education 🎓

Dr. Lui completed his M.B.B.S. from the University of Hong Kong in 1978, followed by an internal medicine residency (1978–1982) at the same institution; he then undertook neurology fellowship training at Newcastle General Hospital, UK (1982–1984), and a neurology residency at UC Davis (1995–1999), also serving as Chief Resident; his qualifications include being a Diplomate of the American Board of Psychiatry and Neurology, Fellow of the Royal College of Physicians (Edinburgh), Fellow of the Hong Kong Academy of Medicine, and Fellow of the American Academy of Neurology.

Experience 👨‍🏫

Dr. Lui has served as Expert Consultant and Reviewer for the Medical Board of California, Professor and Course Director at CNUCOM since 2014, Chair of Clinical Sciences, and Vice Chair of Education; formerly, he was Staff Neurologist and Chief of Neurology at Kaiser Permanente, Clinical Professor at UC Davis, and practiced as a neurologist and internist in Hong Kong; his roles spanned clinical practice, academic leadership, curriculum design, quality assurance, and international consultancy.

Awards & Recognitions 🏅

Dr. Lui received the 2022 A.B. Baker Teacher Recognition Award from the American Academy of Neurology, the ITLE University Distinguished Teacher Award in 2021, and multiple CNUCOM Professor of the Year Awards (2019–2023); his national recognitions include listings in America’s Top Physicians and Sacramento Magazine’s Top Doctors; he won the Croucher Fellowship (1982), John Anderson Gold Medal (1978), and several medical school scholarships for academic excellence, including the Li Shu Fan Prize in Pharmacology.

Research Interests 🔬

Dr. Lui’s academic and clinical interests lie in neurology education, vascular neurology, neuroimaging, and multiple sclerosis, with a deep commitment to medical pedagogy and curriculum leadership; his research integrates neurodiagnostic techniques with clinical neurology, particularly in imaging-based teaching, and he has presented regularly at neuroradiology conferences and contributed to educational innovation in neurology training at both Kaiser Permanente and CNUCOM, reflecting a lifelong dedication to mentoring, patient care, and advancing neurologic knowledge.

Publications

Lucas Muñoz-Lopez | Neuroscience | Best Academic Researcher Award

Published on by Cognitive Scientist Awards

Dr. Lucas Muñoz-Lopez | Neuroscience | Best Academic Researcher Award

El Dr. Lucas Muñoz-López 🎓 es logopeda neurológico especializado en rehabilitación logopédica en daño neurológico 🧠, con amplia experiencia clínica y académica 👨‍🏫. Tras graduarse en Logopedia por la Universidad de Granada en 2015, combinó práctica profesional y formación de posgrado, incluyendo dos másteres y un doctorado con mención Cum Laude 🏅. Ha ejercido como docente universitario en Melilla y Ceuta, y colabora en investigación con publicaciones en revistas como Frontiers in Psychology 📖. Además, ha tutorizado numerosos TFG y TFM 🎓. Su trabajo integra logopedia clínica, investigación sobre alteraciones de la comunicación y neurociencias, aportando al avance académico y a la rehabilitación de pacientes. Es autor de un libro publicado y miembro activo en proyectos de evaluación y tratamiento en contextos educativos y sanitarios 🏥. Su pasión por la docencia y la terapia lo posiciona como referente en logopedia clínica e investigación 📈.

Profile

Education 🎓

Dr. Muñoz-López 🧠 inició su carrera académica con el Grado en Logopedia (2015) en la Universidad de Granada 🎓, complementándolo ese mismo año con un Máster en Logopedia Clínica en Daño Cerebral (Isep Clinic, Madrid) 💡. En 2017 completó su segundo máster en Neurociencias Básicas y Aplicadas y Dolor en la Facultad de Medicina de Granada 🔬. Culminó su formación con un Doctorado en Psicología y Logopedia en la Universidad de Granada (2021) con mención Cum Laude 🏅, convirtiéndose en experto en alteraciones de la comunicación y rehabilitación neurológica 🧬. Su formación académica combina sólidos conocimientos clínicos, teóricos y metodológicos para abordar con éxito la intervención logopédica y la investigación científica 🏛️. Además, su trabajo refleja una constante actualización y compromiso con la excelencia educativa y terapéutica 💯.

Experience 👨‍🏫

Desde 2015, el Dr. Muñoz-López 🩺 ha desarrollado una sólida trayectoria profesional como logopeda clínico, combinando práctica asistencial con docencia universitaria 👨‍🏫. Ha ejercido en el Centro de Valoración y Orientación de Granada como Auxiliar Técnico en Logopedia 🏥, además de impartir clases en los campus de Ceuta y Melilla de la Universidad de Granada 📚. Ha sido tutor de TFG y TFM en varias universidades, incluyendo la Universidad de Granada y la Universidad Internacional de La Rioja ✍️. Su experiencia docente abarca asignaturas de logopedia, neuropsicología y psicopedagogía en grados y másteres universitarios 🎓. Además, colabora activamente en proyectos de intervención educativa, rehabilitación y formación de futuros profesionales. Su enfoque multidisciplinar y experiencia en contextos clínicos y penitenciarios 🏛️ le permiten aplicar soluciones eficaces e innovadoras en su área.

Awards & Recognitions 🏅

Dr. Muñoz-López ha recibido mención Cum Laude 🎖️ por su tesis doctoral en Psicología y Logopedia en la Universidad de Granada (2021) 🏅. Su tesis fue publicada como libro 📗, reafirmando su valor académico. Ha logrado publicar en la revista Frontiers in Psychology (Q2, JCR 2.99) 🧠, destacándose en el área de psicología y neurociencias. También ha publicado en la revista Journal for Educators, Teachers and Trainers, indexada en bases relevantes como Scopus y Dialnet 📖. Su libro fue editado por la Editorial Académica Española, con índice ICEE de 0.299 📘. Estos reconocimientos consolidan su reputación científica, reflejando la calidad y relevancia de su producción académica, así como su compromiso con la excelencia investigadora y docente 🧑‍🔬✨.

Research Interests 🔬

El Dr. Muñoz-López centra su investigación en la rehabilitación logopédica de alteraciones de la comunicación 🗣️, disfagia 🥄 y terapia miofuncional 💪, con especial atención a contextos neurológicos y penitenciarios 🏛️. Su trabajo profundiza en la intersección entre neurociencias, psicología y logopedia 🧠, explorando tanto enfoques clínicos como educativos. Ha contribuido al avance del conocimiento en alteraciones del lenguaje, evaluación cognitiva y técnicas de intervención para pacientes con daño cerebral adquirido 🧬. Además, participa en estudios sobre integración social, intervención educativa en contextos de riesgo y psicología forense ⚖️. Su enfoque combina metodología cuantitativa, intervención basada en evidencia y aplicación clínica, orientado siempre a mejorar la calidad de vida de las personas con trastornos de la comunicación 💬💡.

Publications

  • Validation and Spanish Adaptation of the Resilience Scale ER-23 in a University Population

    Healthcare
    2025-04-12 | Journal article
    DOI: 10.3390/healthcare13080886
    CONTRIBUTORS: Isabel Ramírez-Uclés; Julia Otero; F. Pablo Holgado-Tello; Lucas Muñoz-López; María B. Sánchez-Barrer

  • Analysis of writing in personality disorders in prison population

    Frontiers in Psychiatry
    2024 | Journal article
    DOI: 10.3389/fpsyt.2024.1391463
    EID:
    Part ofISSN: 16640640
    CONTRIBUTORS: Muñoz-López, L.; Fernández-García-Valdecasas, B.; López-Rodríguez, S.; Sánchez-Barrera, M.B.

  • Transformation of Higher Education: Discussion of the Dimensions, Trends and Scenarios of Change in Ibero-America

    Education Sciences
    2024 | Journal article
    DOI: 10.3390/educsci14050523
    Part ofISSN: 22277102
    CONTRIBUTORS: Fernández Cruz, M.; Fernández García Valdecasas, B.; Muñoz López, L.; López Rodríguez, S

  • Associations of Reversal Learning Performance With Personality Disorder Profile and Drug Abuse History in a Sample of Prison Inmates

    2024-09-18 | Journal article
    DOI: 10.1177/10731911241278307
    CONTRIBUTORS: Raquel Martín-Ríos; José C. Perales; Francisca López-Torrecillas; Lucas Muñoz Lóp

Jolanta Dorszewska | Neurobiology | Women Researcher Award

Published on by Cognitive Scientist Awards

Dr. Jolanta Dorszewska | Neurobiology | Women Researcher Award

Professor Jolanta Dorszewska is a globally recognized neuroscientist and pharmacologist based at Poznan University of Medical Sciences, Poland 🧠🇵🇱. She leads the Laboratory of Neurobiology, exploring the molecular and genetic basis of neurodegenerative diseases 🧬. With over 35 years of academic experience, her work spans neurochemistry, clinical neurology, and genetic research in Alzheimer’s and Parkinson’s disease 🧪. A prolific author, she has contributed to 80+ research papers, 50+ reviews, and 30+ book chapters 📚. She serves on editorial boards of top neuroscience journals and holds leadership roles in national and international neurological societies 🌍.

Profile

Education 🎓

Prof. Dorszewska earned her M.Sc. in Pharmacy with distinction from Poznan University of Medical Sciences in 1987 🏅. She completed board certifications in Pharmaceutical Analytics (1990 & 1997) and received her Ph.D. in 1996 🧪. In 2004, she qualified as an Associate Professor and achieved full Professorship in 2016 🎓. Her academic growth includes training in medical genetics from 2012 to 2020 🧬. Her education reflects an evolving blend of pharmacy, neurobiology, and genetics, forming the foundation of her current research excellence 💡.

Experience 👨‍🏫

Prof. Dorszewska began as an Assistant in the Dept. of Pharmacy (1987-88), then in Clinical Neurochemistry (1988-96) at PUMS 👩‍🔬. She was a Research Scientist in New York (1999–2000) 🗽 and has led the Laboratory of Neurobiology since 2004 🧠. She became Full Professor in 2022 🏛️. She also lectured at the National High Medical School in Pila (2012–2018) 📖. Her career blends hands-on research, global collaboration, and dedicated academic leadership 📚. She continues to mentor, publish, and drive innovations in neurology and neurochemistry 🚀

Awards & Recognitions 🏅

Awards and Honors:
Prof. Dorszewska is a Local Honorary Member of the 12th World Congress on Controversies in Neurology (2018) 🌐. She has served as Guest Editor for 6 prestigious theme issues and holds editorial roles in top-tier journals like Frontiers in Molecular Neuroscience and Current Alzheimer Research 📘. A section and associate editor for journals across the USA, UK, and Poland 🌍, she’s a key figure in scientific publishing 🖋️. She’s affiliated with the Polish Academy of Sciences and international neurological societies and has co-edited 5 books 📚.

Research Interests 🔬

Research Focus:
Her research spans lipid metabolism in hypoxia 🧫, cerebral sterols 🧠, neurotransmitters (serotonin, dopamine) 🧪, apoptosis in aging and disease (Alzheimer’s, Parkinson’s) 💔, and gene polymorphisms (MTHFR, MAO-B, PARK) 🧬. She investigates homocysteine metabolism, catecholamine pathways, and molecular changes in neurodegeneration 🧠. Since 2009, she’s focused on genetic mutations (PARK, APOE), biomarkers (ASN, microRNAs), and migraine genetics ⚙️. She uses advanced techniques like HPLC, PCR, ELISA, and immunohistochemistry 🔍. Her interdisciplinary work integrates neurobiology, pharmacogenomics, and molecular neuroscience in tackling brain diseases 🚀.

Publications 

  • Genetic variants of ZNF746 and the level of plasma Parkin, PINK1, and ZNF746 proteins in patients with Parkinson’s disease

    IBRO Neuroscience Reports
    2025-06 | Journal article
    DOI: 10.1016/j.ibneur.2025.01.016
    CONTRIBUTORS: Jolanta Dorszewska; Jolanta Florczak-Wyspiańska; Bartosz Słowikowski; Wojciech Owecki; Oliwia Szymanowicz; Ulyana Goutor; Mateusz Dezor; Paweł P. Jagodziński; Wojciech Kozubski

  • Kinesiotherapeutic Possibilities and Molecular Parameters in Multiple Sclerosis

    Sclerosis
    2025-04-03 | Journal article
    DOI: 10.3390/sclerosis3020013
    CONTRIBUTORS: Katarzyna Wiszniewska; Małgorzata Wilk; Małgorzata Wiszniewska; Joanna Poszwa; Oliwia Szymanowicz; Wojciech Kozubski; Jolanta Dorszewsk

  • Unraveling the Role of Proteinopathies in Parasitic Infections

    Biomedicines
    2025-03-03 | Journal article
    DOI: 10.3390/biomedicines13030610
    CONTRIBUTORS: Mikołaj Hurła; Damian Pikor; Natalia Banaszek-Hurła; Alicja Drelichowska; Jolanta Dorszewska; Wojciech Kozubski; Elżbieta Kacprzak; Małgorzata Paul

  • Expression of Neuronal Nicotinic Acetylcholine Receptor and Early Oxidative DNA Damage in Aging Rat Brain—The Effects of Memantine

    International Journal of Molecular Sciences
    2025-02-14 | Journal article
    DOI: 10.3390/ijms26041634
    CONTRIBUTORS: Małgorzata Anna Lewandowska; Agata Różycka; Teresa Grzelak; Bartosz Kempisty; Paweł Piotr Jagodziński; Margarita Lianeri; Jolanta Dorszewska

Yuanyuan Li | Movement Disorder | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Yuanyuan Li | Movement Disorder | Best Researcher Award

🧠 Dr. Yuanyuan Li is a dedicated neurologist and researcher specializing in neurodegenerative diseases, particularly Parkinson’s disease and REM sleep behavior disorder. She obtained her Ph.D. in Neurology from Shanghai Jiao Tong University School of Medicine and has been actively involved in cutting-edge research at Ruijin Hospital’s Department of Neurology. As a project leader, she has explored the role of α-synuclein in dopaminergic neurons, investigating its transport pathways and impact on cell viability. Dr. Li has authored multiple high-impact publications in renowned journals such as Neurology and J Neuroinflammation. Her work has contributed significantly to understanding the early biomarkers of neurodegenerative disorders. She has received prestigious awards, including the National Scholarship for Doctoral Students and the Outstanding Graduate Award from Shanghai Jiao Tong University. With numerous conference presentations and accolades, Dr. Li continues to drive forward advancements in neurodegenerative disease research. ✨📚

Profile

Education 🎓

🎓 Dr. Yuanyuan Li completed her Ph.D. in Neurology at Shanghai Jiao Tong University School of Medicine, where she focused on neurodegenerative diseases, particularly Parkinson’s disease and REM sleep behavior disorder. Her doctoral research emphasized the role of α-synuclein in dopaminergic neurons, uncovering its impact on neurodegeneration. Throughout her academic journey, Dr. Li consistently demonstrated excellence, earning the First-Class Academic Scholarship and the Meritorious Student Award. She was recognized as an Outstanding Graduate and received the prestigious National Scholarship for Doctoral Students. Beyond coursework, she actively engaged in translational research, bridging laboratory findings with clinical applications. Her education has provided a strong foundation in neurobiology, molecular neuroscience, and clinical neurology. With a passion for uncovering early biomarkers of neurodegeneration, Dr. Li’s educational background has shaped her into a leading researcher in the field. 📖🧬

Experience 👨‍🏫

Dr. Yuanyuan Li has extensive research experience at Ruijin Hospital’s Department of Neurology, affiliated with Shanghai Jiao Tong University School of Medicine. As a principal investigator, she led the Shanghai Jiao Tong University Doctoral Innovation Fund project, studying α-synuclein’s transport mechanisms in dopaminergic neurons and its effects on cell viability. Her expertise spans biomarker discovery, neuroinflammation, and disease progression in neurodegenerative disorders. She has collaborated on numerous high-impact studies published in Neurology, J Neuroinflammation, and NPJ Parkinson’s Disease. Dr. Li has also presented her findings at major conferences, including the National Neurology Conference and the Oriental Neurology Conference. Her experience in both basic and clinical research allows her to bridge the gap between laboratory discoveries and patient applications, advancing diagnostic and therapeutic strategies for Parkinson’s disease and related disorders. 🏥🧠

Awards & Recognitions 🏅

Dr. Yuanyuan Li has received numerous prestigious awards for her contributions to neurology and neuroscience research. She was awarded the National Scholarship for Doctoral Students, recognizing her academic excellence and groundbreaking research. She also received the Outstanding Graduate Award and the Meritorious Student Award from Shanghai Jiao Tong University. Her outstanding academic performance earned her the First-Class Academic Scholarship, demonstrating her dedication to advancing neurological research. Dr. Li has been recognized for her contributions at major conferences, winning the “Excellent Paper Presentation” award at the Oriental Neurology Conference. Additionally, she secured First Prize for Poster Presentation at the “Bo Ji Yi Yuan” Academic Forum. Her accolades reflect her commitment to advancing our understanding of neurodegenerative diseases, particularly Parkinson’s disease. These honors highlight her as a rising star in the field of neurology. 🏅📜

Research Interests 🔬

🧪 Dr. Yuanyuan Li’s research focuses on neurodegenerative diseases, with an emphasis on Parkinson’s disease, REM sleep behavior disorder (RBD), and α-synuclein pathology. Her work explores the molecular mechanisms driving these disorders, particularly the role of α-synuclein in dopaminergic neurons, its transport pathways, and its impact on cell viability. She has also investigated immune biomarkers, neuroinflammation, and genetic variants associated with Parkinson’s progression. Dr. Li’s studies have contributed to identifying predictive markers for early-stage neurodegenerative diseases, aiding in early diagnosis and potential therapeutic interventions. Through her publications in top journals like Neurology, J Neuroinflammation, and NPJ Parkinson’s Disease, she has advanced knowledge in the field. Her work integrates clinical and experimental neuroscience, bridging gaps between laboratory findings and real-world applications. Dr. Li’s research continues to shape the understanding of neurodegenerative disorders and their early detection. 🧬🔍

 

4Publications 

  • Gene Polymorphisms of Parkinson’s Disease Risk Locus and Idiopathic REM Sleep Behavior Disorder

    Biomedicines
    2025-03-24 | Journal article
    DOI: 10.3390/biomedicines13040788
    CONTRIBUTORS: Min Zhong; Yang Jiao; Aonan Zhao; Mengyue Niu; Jinjun Ran; Jun Liu; Yuanyuan Li

  • Understanding Causal Relationships Between Imaging-Derived Phenotypes and Parkinson’s Disease: A Mendelian Randomization and Observational Study

    Biomedicines
    2025-03-18 | Journal article
    DOI: 10.3390/biomedicines13030747
    CONTRIBUTORS: Yichi Zhang; Min Zhong; Zhao Yang; Xiaojin Wang; Zhongxun Dong; Liche Zhou; Qianyi Yin; Bingshun Wang; Jun Liu; Yuanyuan Li et al.

  • Understanding Causal Relationships between Imaging-Derived Phenotypes and Parkinson’s Disease: A Mendelian Randomization and Observational Study

    2025-02-05 | Preprint
    DOI: 10.20944/preprints202502.0350.v1
    CONTRIBUTORS: Yichi Zhang; Min Zhong; Zhao Yang; Xiaojin Wang; Zhongxun Dong; Liche Zhou; Qianyi Yin; Bingshun Wang; Jun Liu; Yuanyuan Li et al.

  • Network disruption based on multi-modal EEG-MRI in α-synucleinopathies

    Frontiers in Neurology
    2024 | Journal article
    DOI: 10.3389/FNEUR.2024.1442851
    WOSUID: WOS:001304283700001
    CONTRIBUTORS: Wang, Chunyi; Hu, Jiajia; Li, Puyu; Zhang, Ming; Zhou, Liche; Luo, Ningdi; Zhu, Xue; Yin, Qianyi; Zhong, Min; Zhou, Xinyi et al.